Rebif 44mcg Injection

​​The efficacy of Rebif has been calculated in patients with relapsing-remitting Multiple Sclerosis at certain doses ranging from 11 to 44 micrograms (3-12 million IU), administered subcutaneously (three times per week). Rebif 22 mcg has been observed to minimize the incidence (approximately 30% over 2 years) and severity of clinical relapses in patients with at least 2 exacerbations in the previous 2 years along with an EDSS of 0-5.0 at entry. The average count of patients with disability progression, as defined by at least one one-point increase in EDSS confirmed three months later, was decreased from 39% (placebo) to 30% (Rebif 22 mcg).​​

It is advised to seek immediate help from a professional healthcare provider if you experience any of the following or other side effects.

​Stomach ache

Chills 

Cough

Chest pain

Back pain

Weakness

Unusual tiredness

Muscle pain

Depression

Skin rash

Headache 

Low count of blood cells

Unusual bleeding

Joint pain

Painful urination

​​Rebif injection (Interferon beta-1a) is used in the treatment of relapsing multiple sclerosis (MS) in adults, aged over 18. There are three available options for injecting Rebif (Interferon beta-1a). Your healthcare provider will recommend the dose according to your medical condition and requirements. There are two dosing options available: 22 mcg and 44 mcg. There are three available options for injecting Rebif (Interferon beta-1a). Your healthcare provider will recommend the dose according to your medical condition and requirements. There are two dosing options available: 22 mcg and 44 mcg. ​​

It is advisable not to miss any dose. In case you miss a dose of Rebif 44mcg Injection consult your doctor soon.

Missing the dose will impact the overall health of the patients. So, it is always advisable to follow the prescription of the doctor strictly.